Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;94:2072-2076

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haider, A. W.
Right arrow Articles by Davies, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haider, A. W.
Right arrow Articles by Davies, G. J.

(Circulation. 1996;94:2072-2076.)
© 1996 American Heart Association, Inc.


Articles

Serum Lipoprotein(a) Level Is Related to Thrombin Generation and Spontaneous Intermittent Coronary Occlusion in Patients With Acute Myocardial Infarction

Agha W. Haider, MD, PhD; Felicita Andreotti, MD, PhD; Gilbert R. Thompson, FRCP; Cornelis Kluft, PhD; Attilio Maseri, FRCP; Graham J. Davies, FRCP

the Division of Clinical Cardiology and MRC Lipoprotein Team, Royal Postgraduate Medical School, Hammersmith Hospital, London, England (A.W.H., G.R.T., G.J.D.); TNO Gaubius Laboratory, Leiden, Netherlands (C.K.); and Istituto di Cardiologia, Catholic University of the Sacred Heart, Rome, Italy (F.A., A.M.).

Correspondence to Dr Graham J. Davies, FRCP, Division of Cardiology, Royal Postgraduate Medical School, Hammersmith Hospital, Ducane Road, London W12 ONN, England or Dr A.W. Haider, MD, PhD, Boston University School of Medicine, Framingham Study, 5 Thurber St, Framingham, MA 01701. E-mail AGHA@FRAM.NHLBI.NIH.GOV.

Background Thrombotic occlusion of the infarct-related coronary artery is often intermittent in the early, evolving phase of acute myocardial infarction. To assess their relationship to this pattern of coronary occlusion, serum or plasma concentrations of cholesterol, triglyceride, lipoprotein(a), and coagulation and fibrinolytic factors were measured in venous blood before the initiation of thrombolytic therapy.

Methods and Results Thirty-two patients (23 men, 9 women; age, 30 to 70 years) with acute myocardial infarction received intravenous recombinant tissue plasminogen activator (20 to 60 megaunits) within 6 hours of the onset of symptoms. Continuous ECG ST-segment recording demonstrated intermittent occlusion of the infarct-related coronary artery in 12 patients (group 1) before the start of thrombolytic treatment and persistent occlusion in 20 patients (group 2). Groups 1 and 2 were similar in age, sex, race, duration of symptoms, blood sample collection time, location of the infarct-related coronary artery, and extent of coronary artery disease. The serum level (median [interquartile range]) of lipoprotein(a) was 34 (13 to 47) mg/dL versus 11.5 (5 to 27) mg/dL (P=.02), and the plasma level (median [interquartile range]) of thrombin–antithrombin III complex was 10.85 (6.4 to 21.5) versus 6.8 (4.2 to 8.7) µg/L-1 (P<.04) in groups 1 and 2, respectively. The levels of the other factors were similar in both groups.

Conclusions The phenomenon of spontaneous intermittent closure and reopening of coronary arteries early during acute myocardial infarction in humans is associated with a higher level of lipoprotein(a) and of a marker of thrombin generation, suggesting that lipoprotein(a) and thrombin are closely related to coronary patency in these patients.


Key Words: lipoproteins • occlusion • myocardial infarction • coagulation • fibrinolysis • thrombosis




This article has been cited by other articles:


Home page
CirculationHome page
T. N. James
Homage to James B. Herrick: A Contemporary Look at Myocardial Infarction and at Sickle-Cell Heart Disease : The 32nd Annual Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association
Circulation, April 18, 2000; 101(15): 1874 - 1887.
[Full Text] [PDF]


Home page
JAMAHome page
A. W. Haider
Elevated Lipoprotein(a) and Premature Coronary Heart Disease
JAMA, January 15, 1997; 277(3): 209 - 210.
[Abstract] [PDF]